DEA Schedule 1 Drug Manufacturing
Prioritizing the research and development of natural, safe and effective botanical drugs
Irvine Labs was established in 1997 and has over a decade of experience in research and development of drugs and therapeutics made from naturally occurring active pharmaceutical ingredients.
Our pipeline of drug candidates are in process of going through the FDA approval process at Phase II or more.
As a DEA Schedule 1 Bulk Manufacturer, we have the unique expertise in cannabinoids and components from Schedule 1 plants and compounds.